GFG Resources Inc (TSXV:GFG)

Silk Road Medical Income Statement

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Selling, General & Admin	0.92	0.98	0.89	0.81	0.84	0.86
Other Operating Expenses	-0.24	-0.24	-	-	-	-
Operating Expenses	1	1.02	11.92	1.09	1.12	1.21
Operating Income	-1	-1.02	-11.92	-1.09	-1.12	-1.21
Interest Expense	-0.04	-0.03	-0.07	-0.01	-0.01	-0.01
Interest & Investment Income	0.14	0.09	0.07	0.01	0.02	0.08
Currency Exchange Gain (Loss)	0.03	0.01	0.02	0.03	-0.06	0.1
Other Non Operating Income (Expenses)	-0.21	-0.14	0.06	0.17	0.78	0.24
EBT Excluding Unusual Items	-1.08	-1.1	-11.85	-0.9	-0.39	-0.81
Gain (Loss) on Sale of Assets	3.11	-	-	0.04	-	-
Pretax Income	2.06	-1.1	-11.85	-0.86	-0.39	-0.81
Income Tax Expense	0.33	0.15	-	-	-	-
Net Income	1.73	-1.25	-11.85	-0.86	-0.39	-0.81
Net Income to Common	1.73	-1.25	-11.85	-0.86	-0.39	-0.81
Shares Outstanding (Basic)	249	217	183	149	133	109
Shares Outstanding (Diluted)	250	217	183	149	133	109
Shares Change (YoY)	18.55%	18.76%	23.21%	12.05%	22.10%	18.54%
EPS (Basic)	0.01	-0.01	-0.06	-0.01	-0.00	-0.01
EPS (Diluted)	0.01	-0.01	-0.06	-0.01	-0.00	-0.01
Free Cash Flow	-4.58	-3.88	-4.2	-3.1	-5.53	-3.51
Free Cash Flow Per Share	-0.02	-0.02	-0.02	-0.02	-0.04	-0.03
EBITDA	-0.99	-1.02	-1.17	-1.09	-1.11	-1.2
D&A For EBITDA	0	0	10.76	0	0.01	0.01
EBIT	-1	-1.02	-11.92	-1.09	-1.12	-1.21

Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.